| Stockholders' Equity |
8. Stockholders’ Equity Common Stock Reserved for Issuance The Company’s shares of common stock reserved for issuance as of the periods indicated were as follows:
|
|
|
|
|
|
|
|
|
|
|
March 31, 2026 |
|
|
December 31, 2025 |
|
April 2017 Warrants |
|
|
24,725 |
|
|
|
24,725 |
|
June 2017 Warrants |
|
|
41,736 |
|
|
|
41,736 |
|
December 2018 Warrants |
|
|
11,332 |
|
|
|
11,332 |
|
Pre-funded PIPE Warrants |
|
|
3,615,516 |
|
|
|
3,615,516 |
|
2021 Pre-funded Warrants |
|
|
32,175,172 |
|
|
|
32,175,172 |
|
2023 Pre-funded Warrants |
|
|
5,666,667 |
|
|
|
5,666,667 |
|
2025 Pre-funded Warrants |
|
|
7,142,857 |
|
|
|
7,142,857 |
|
Stock options outstanding |
|
|
12,873,658 |
|
|
|
13,243,462 |
|
Issued and nonvested RSUs |
|
|
6,800,000 |
|
|
|
6,905,000 |
|
Total shares reserved |
|
|
68,351,663 |
|
|
|
68,826,467 |
|
Warrants The following table summarizes the outstanding warrants for the Company’s common stock as of March 31, 2026:
|
|
|
|
|
|
|
|
|
Expiration Date |
|
Shares Underlying
Outstanding Warrants |
|
|
Exercise Price |
|
April 2027 |
|
|
24,725 |
|
|
$ |
2.87 |
|
June 2027 |
|
|
41,736 |
|
|
$ |
2.87 |
|
December 2028 |
|
|
11,332 |
|
|
$ |
2.87 |
|
None |
|
|
48,600,212 |
|
|
$ |
0.001 |
|
|
|
|
48,678,005 |
|
|
|
|
Accumulated Other Comprehensive Loss Information The components of accumulated other comprehensive loss as of the dates indicated and the change during the period were (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign Exchange Translation Adjustment |
|
|
Unrealized Gain (Loss) on ST Investments |
|
|
Total Accumulated Other Comprehensive Loss |
|
Balance, December 31, 2024 |
|
$ |
(984 |
) |
|
$ |
234 |
|
|
$ |
(750 |
) |
Change |
|
$ |
665 |
|
|
$ |
(2 |
) |
|
$ |
663 |
|
Balance, December 31, 2025 |
|
$ |
(319 |
) |
|
$ |
232 |
|
|
$ |
(87 |
) |
Change |
|
$ |
(95 |
) |
|
$ |
(247 |
) |
|
$ |
(342 |
) |
Balance, March 31, 2026 |
|
$ |
(414 |
) |
|
$ |
(15 |
) |
|
$ |
(429 |
) |
|